Ophthotech reported $19.17M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alimera Sciences ALIM:US $ 17.01M 4.41M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
Bioline Rx BLRX:US $ 9.1M 0.62M
Cytrx CYTR:US 3.1M 633.56K
Insmed INSM:US $ 125.25M 9.92M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Novartis NOVN:VX SF 29807M 401M
Ophthotech OPHT:US $ 19.17M 9.04M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M